ABIOMED, Inc.  

(Public, NASDAQ:ABMD)   Watch this stock  
Find more results for ABMD
25.08
-0.22 (-0.87%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 25.04 - 25.63
52 week 17.61 - 30.77
Open 25.51
Vol / Avg. 219,548.00/535,223.00
Mkt cap 998.64M
P/E 139.33
Div/yield     -
EPS 0.18
Shares 39.82M
Beta 1.54
Inst. own 99%
May 1, 2014
Q4 2014 Abiomed, Inc. Earnings Release - 9:30AM EDT - Add to calendar
May 1, 2014
Q4 2014 Abiomed, Inc. Earnings Conference Call - 8:00AM EDT - Add to calendar
Feb 12, 2014
Abiomed, Inc. at Leerink Swann Global Healthcare Conference
Jan 30, 2014
Q3 2014 Abiomed, Inc. Earnings Release
Jan 30, 2014
Q3 2014 Abiomed, Inc. Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 9.51% 9.50%
Operating margin 9.94% 10.46%
EBITD margin - 12.25%
Return on average assets 9.41% 9.27%
Return on average equity 11.33% 11.40%
Employees 467 -
CDP Score - -

Address

22 Cherry Hill Drive
DANVERS, MA 01923
United States - Map
+1-978-7775410 (Phone)
+1-978-7778411 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ABIOMED, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. In April 2014, the Company acquired exclusive license from collaboration partner Opsens Inc.

Officers and directors

Michael R. Minogue Chairman of the Board, President, Chief Executive Officer
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert L. Bowen Chief Financial Officer, Vice President, Treasurer
Age: 63
Bio & Compensation  - Reuters
David M. Weber Chief Operating Officer
Age: 51
Bio & Compensation  - Reuters
William J. Bolt Senior Vice President - Global Product Operations
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael G. Howley Vice President, General Manager - Global Sales and Marketing
Age: 49
Bio & Compensation  - Reuters
Andrew J Greenfield Vice President - Healthcare Solutions
Age: 40
Bio & Compensation  - Reuters
Dorothy E. Puhy Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
W. Gerald Austen M.D. Independent Director
Age: 83
Bio & Compensation  - Reuters
Louis E. Lataif Independent Director
Age: 74
Bio & Compensation  - Reuters
Martin P. Sutter Independent Director
Age: 58
Bio & Compensation  - Reuters